Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-122' Or cancer = '' Total: 53 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-122 acute myeloid leukemia down Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential.
hsa-mir-122 bladder cancer down MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.
hsa-mir-122 breast cancer down MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R.
hsa-mir-122 breast cancer down Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
hsa-mir-122 gallbladder carcinoma down miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.
hsa-mir-122 gastric cancer down MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.
hsa-mir-122 gastric cancer down Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
hsa-mir-122 glioma down miR-122/Wnt/?-catenin regulatory circuitry sustains glioma progression.
hsa-mir-122 glioma down Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
hsa-mir-122 glioma down MiR-122 inhibits cell proliferation and induces apoptosis by targeting runt-related transcription factors 2 in human glioma.
hsa-mir-122 hepatocellular carcinoma down A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
hsa-mir-122 hepatocellular carcinoma up Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
hsa-mir-122 hepatocellular carcinoma down MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
hsa-mir-122 hepatocellular carcinoma up Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-122 hepatocellular carcinoma down MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway.
hsa-mir-122 hepatocellular carcinoma down MicroRNAs in Hepatobiliary and Pancreatic Cancers.
hsa-mir-122 hepatocellular carcinoma up Epigenetic regulation of miR-122 by PPAR? and hepatitis B virus X protein in hepatocellular carcinoma cells.
hsa-mir-122 hepatocellular carcinoma down miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3.
hsa-mir-122 hepatocellular carcinoma down miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/?-catenin pathway.
hsa-mir-122 hepatocellular carcinoma down Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis.
hsa-mir-122 hepatocellular carcinoma down miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
hsa-mir-122 hepatocellular carcinoma down Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
hsa-mir-122 hepatocellular carcinoma down Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
hsa-mir-122 hepatocellular carcinoma down Crosstalk between microRNA-122 and FOX family genes in HepG2 cells.
hsa-mir-122 hepatocellular carcinoma down MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/?-cadherin signaling pathway.
hsa-mir-122 hepatocellular carcinoma down MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
hsa-mir-122 hepatocellular carcinoma down Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level.
hsa-mir-122 hepatocellular carcinoma down miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
hsa-mir-122 hepatocellular carcinoma down LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.
hsa-mir-122 hepatocellular carcinoma down microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.
hsa-mir-122 liver cancer down MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
hsa-mir-122 osteosarcoma down Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
hsa-mir-122 pituitary carcinoma up MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
hsa-mir-122 renal cell carcinoma up MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2.
hsa-mir-122 renal clear cell carcinoma up miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-122* hepatocellular carcinoma down The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry.
hsa-mir-122-3p lung cancer down MicroRNA-122-3p inhibits tumor cell proliferation and induces apoptosis by targeting Forkhead box O in A549 cells.
hsa-mir-122-5p gastric cancer down miR-122-5p inhibits tumor cell proliferation and induces apoptosis by targeting MYC in gastric cancer cells.
hsa-mir-122-5p gastric cancer down MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
hsa-mir-122-5p hepatocellular carcinoma down Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
hsa-mir-122-5p hepatocellular carcinoma down Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
hsa-mir-122-5p malignant melanoma up [miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
hsa-mir-1225-5p gastric cancer down MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?-catenin signaling.
hsa-mir-1228 breast cancer up MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
hsa-mir-1228 gastric cancer down microRNA-1228(?) impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor.
hsa-mir-1228 hepatocellular carcinoma up miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.
hsa-mir-1228* gastric cancer down Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer.
hsa-mir-1229 breast cancer up MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/?-catenin signaling in breast cancer.
hsa-mir-1229 colorectal cancer up Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
hsa-mir-122a gastrointestinal cancer down MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.
hsa-mir-122a hepatocellular carcinoma down Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
hsa-mir-122a hepatocellular carcinoma down Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
hsa-mir-122a hepatocellular carcinoma down [MicroRNA profiling in patients with hepatocellular carcinoma].